Tempest Therapeutics, Inc.
TPST
$10.03
$0.6757.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 23.75% | 4.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.16% | -21.43% | |||
| Operating Income | 27.16% | 21.43% | |||
| Income Before Tax | 27.53% | 21.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.53% | 21.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.53% | 21.38% | |||
| EBIT | 27.16% | 21.43% | |||
| EBITDA | 27.32% | 21.64% | |||
| EPS Basic | 34.49% | 27.88% | |||
| Normalized Basic EPS | 34.49% | 27.88% | |||
| EPS Diluted | 34.49% | 27.88% | |||
| Normalized Diluted EPS | 34.49% | 27.88% | |||
| Average Basic Shares Outstanding | 10.63% | 9.02% | |||
| Average Diluted Shares Outstanding | 10.63% | 9.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||